Xiaoshan Feng - Concepedia

Author

Xiaoshan Feng

First Affiliated Hospital of Henan University of Science and Technology ORCID

Also Known As

X. S. Feng, XIAO-SHAN FENG, XIAOSHAN FENG, Xiao-Shan Feng, Xiao-shan Feng, Xiaoshan Feng

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

First Affiliated Hospital of Henan University of Science and Technology Henan University of Science and Technology Henan Cancer Hospital Xinxiang Medical University First Affiliated Hospital of Zhengzhou University

About

Xiaoshan Feng is an author at First Affiliated Hospital of Henan University of Science and Technology specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	1K
2	Engineering	1	1	34
3	Health Sciences	1	1	10
4	Public Health	1	1	12
5	Biomedical Engineering	1	1	34

Xiaoshan Feng

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1 Lidong Wang, Fuyou Zhou, Xue-Min Li, Nature Genetics Genome-wide Association StudyChinese SubjectsEsophageal CancerGeneticsGenetic Epidemiology	2010	416
Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer Shegan Gao, Shuoguo Li, Zhikun Ma, Infectious Agents and Cancer	2016	314
Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations Chen Wu, Zhaoming Wang, Xin Song, Nature Genetics	2014	204
Up regulation of the long non-coding RNA NEAT1 promotes esophageal squamous cell carcinoma cell progression and correlates with poor prognosis. Xiaojie Chen, Jinyu Kong, Zhikun Ma, PubMed Esophageal CancerPathologyCancer BiologyTumor BiologyTranscriptional Regulation	2015	119
Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients Ye Chen, Shegan Gao, Jianmin Chen, Cell Biochemistry and Biophysics Pancreatic CancerMedicineCancer GrowthPathologyPancreatic Cancer Patients	2014	94
p53 is required for metformin-induced growth inhibition, senescence and apoptosis in breast cancer cells Puyu Li, Ming Zhao, Amanda B. Parris, Biochemical and Biophysical Research Communications Breast OncologyOncologyMetformin-induced Growth InhibitionMedicineBreast Cancer Cells	2015	78
Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma Shegan Gao, Junqiang Yang, Zhikun Ma, BMC Cancer	2018	73
Chk1 knockdown confers radiosensitization in prostate cancer stem cells Xiaobin Wang, Zhikun Ma, Zheng Xiao, Oncology Reports	2012	59
The Chk1 inhibitor AZD7762 sensitises p53 mutant breast cancer cells to radiation in vitro and in vivo Zhikun Ma, Guoliang Yao, Bo Zhou, Molecular Medicine Reports Breast OncologyAzd7762 TreatmentRadiation EffectRadiation ExposureCell Death	2012	57
Inhibition of glycogen synthase kinase 3 beta (GSK3β) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity Shegan Gao, Shuoguo Li, Xiaoxian Duan, Molecular Carcinogenesis	2017	49

Page 1